Astec LifeSciences Limited

NSE:ASTEC.NS

1217.55 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 4,581.8076,281.6626,765.6615,548.7215,226.0614,309.0123,612.7952,986.7462,592.872,665.2112,069.7061,747.7461,128.4481,094.4391,119.428844.146551.835
Cost of Revenue 4,172.7764,012.4413,908.3643,452.113,406.7612,817.6972,371.811,799.3831,769.2191,825.5731,456.0311,178.052776.758851.765795.744568.684339.908
Gross Profit 409.0312,269.2212,857.2972,096.6111,819.31,491.3151,240.9851,187.363823.651839.637613.675569.694351.689242.674323.684275.462211.927
Gross Profit Ratio 0.0890.3610.4220.3780.3480.3460.3430.3980.3180.3150.2970.3260.3120.2220.2890.3260.384
Reseach & Development Expenses 27.00414.8539.149.2238.9138.7188.595.5272.8075.9462.7554.71100000
General & Administrative Expenses 71.356122.56481.41666.03873.57944.94447.14952.35849.935125.42531.69116.283046.05837.27538.04738.329
Selling & Marketing Expenses 26.28775.102108.33862.97555.78438.71253.991.54609.03824.67547.90800000
SG&A 830.691197.666189.754129.013129.36383.656101.13953.90449.935134.46356.366168.404046.05837.27538.04738.329
Other Expenses 56.439130.6013.2780.0472.4171.1990.812617.737642.76424.4070.5362.0230.10296.63673.04253.70338.194
Operating Expenses 830.6911,843.2061,651.4531,198.3611,136.788806.105676.712677.168692.694424.407407.081418.347281.7142.694110.31791.75176.523
Operating Income -421.66434.5591,203.33897.136684.837685.21564.273510.195-174.415189.761111.49785.04618.01569.629171.788124.15794.502
Operating Income Ratio -0.0920.0690.1780.1620.1310.1590.1560.171-0.0670.0710.0540.0490.0160.0640.1530.1470.171
Total Other Income Expenses Net -195.819-85.0867.928-6.427-71.312-126.169-7.157-222.765-305.372-225.469-95.096-64.278-51.873-30.351-41.579-59.554-40.903
Income Before Tax -617.479349.4731,211.258890.709613.525559.041557.116287.43-174.415189.761111.49787.06918.11769.629171.788124.15794.502
Income Before Tax Ratio -0.1350.0560.1790.1610.1170.130.1540.096-0.0670.0710.0540.050.0160.0640.1530.1470.171
Income Tax Expense -148.56993.534312.432240.021138.254201.387206.74295.64416.22741.93524.98128.0525.37920.85833.36816.85913.755
Net Income -469.295255.649898.586650.489475.111357.368349.04191.177-191.64147.75486.75759.51513.65548.984132.124103.7579.451
Net Income Ratio -0.1020.0410.1330.1170.0910.0830.0970.064-0.0740.0550.0420.0340.0120.0450.1180.1230.144
EPS -23.9313.0445.8733.2324.2918.2817.889.81-9.857.914.743.450.812.8910.98118.42
EPS Diluted -23.9313.0445.8533.2124.2718.2617.849.78-9.827.914.743.430.812.8910.98118.42
EBITDA -59.126893.1411,627.7691,193.042972.227900.548769.013661.813241.729535.753360.011263.129157.78158.28255.007216.378158.255
EBITDA Ratio -0.0130.1420.2410.2150.1860.2090.2130.2220.0930.2010.1740.1510.140.1450.2280.2560.287